Tedizolid Phosphate (TR-701 FA, MK-1986) vs Linezolid for the Treatment of Nosocomial Pneumonia (MK-1986-002)
Clinical trial NCT02019420 · COMPLETED
Trial details
- NCT number
- NCT02019420
- Sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-06
- Primary completion
- 2018-06-22
- Enrollment
- 726
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.